Avant is a medical diagnostic technology company that specializes in biomarker tests that are being developed in the areas of oncology and neurology. Avant provides personalized medicine diagnostic testing capabilities through its TheraLink® Diagnostic Assays, primarily for breast cancer, to assist clinical oncologists in identifying likely responders for over 30 FDA-approved drug treatment regimens. Avant is the leading developer of proteomic technologies for measuring the activation status of key signaling pathways, with applications across several different cancer types, including breast, ovarian and pancreatic that are instrumental in the development of companion diagnostics for molecular-targeted therapies. Avant has used these proteomic technologies to support the drug development programs of many of the top biopharmaceutical companies in the world. For more information please visit www.avantdiagnostics.com.
217 Perry Parkway
Gaithersburg, MD 20877
Medical Diagnostics & Research
Diagnostics & Research
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
Electromedical And Electrotherapeutic Apparatus (3845)